Suppr超能文献

COVID-19大流行期间小儿静脉血栓栓塞症和动脉缺血性卒中的诊断趋势:一项行政数据库研究

Trends in the Diagnosis of Pediatric Venous Thromboembolism and Arterial Ischemic Stroke during the COVID-19 Pandemic: An Administrative Database Study.

作者信息

Kumar Riten, Chen Nan, Lehman Laura L, London Wendy B

机构信息

Dana Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA; Department of Pediatrics, Harvard Medical School, Boston, MA.

Dana Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA.

出版信息

J Pediatr. 2025 Jan;276:114328. doi: 10.1016/j.jpeds.2024.114328. Epub 2024 Sep 30.

Abstract

OBJECTIVE

To investigate trends in the diagnosis of venous thromboembolism (VTE) and arterial ischemic stroke (AIS), and examine the use of pharmacological thromboprophylaxis during the COVID-19 pandemic.

STUDY DESIGN

This retrospective cohort study used the Pediatric Health Information Systems database to investigate patients admitted to a participating hospital between January 1, 2018, and December 31, 2021. International Classification of Diseases, 10th edition codes were used to identify VTE, AIS, and COVID-19. Pharmacy billing codes were used to investigate pharmacological thromboprophylaxis use.

RESULTS

1 759 701 unique patients underwent 2 234 135 inpatient admissions. Rate of VTE increased from 84 cases per 10 000 admissions in 2018-2019 to 108 cases per 10 000 admissions in 2020-2021, representing a 28.6% increase (P < .001). In contrast, the rate of AIS remained stable through the study period. When compared with 2018-2019, children diagnosed with VTE during 2020-2021 had longer hospitalizations and were more likely to be admitted to the intensive care unit. When analysis was limited to 2020-2021, a diagnosis code of COVID-19 was associated with a 1.35-fold (95% CI: 1.24-1.45) increase in the odds of VTE diagnosis, but not AIS. Use of pharmacologic thromboprophylaxis increased from 1.5% of hospitalizations in 2018-2019 to 3.0% of hospitalizations in 2020-2021 (P < .001). When evaluating thromboprophylaxis during 2020-2021, a diagnosis code for COVID-19 was associated with an 11-fold (95% CI: 10.86-11.49; P < .001) increase in the utilization of pharmacological thromboprophylaxis.

CONCLUSIONS

This study found an increase in the rate of VTE among hospitalized children during the pandemic. A diagnosis of COVID-19 was associated with a modest increase in odds of VTE diagnosis, which occurred despite increased use of pharmacological thromboprophylaxis.

摘要

目的

调查静脉血栓栓塞症(VTE)和动脉缺血性卒中(AIS)的诊断趋势,并研究在2019冠状病毒病(COVID-19)大流行期间药物性血栓预防的使用情况。

研究设计

这项回顾性队列研究使用儿科健康信息系统数据库,调查了2018年1月1日至2021年12月31日期间入住参与研究医院的患者。使用国际疾病分类第十版编码来识别VTE、AIS和COVID-19。药房计费编码用于调查药物性血栓预防的使用情况。

结果

1759701名不同患者接受了2234135次住院治疗。VTE的发生率从2018 - 2019年每10000次住院84例增加到2020 - 2021年每10000次住院108例,增长了28.6%(P <.001)。相比之下,在整个研究期间AIS的发生率保持稳定。与2018 - 2019年相比,2020 - 2021年诊断为VTE的儿童住院时间更长,且更有可能入住重症监护病房。当分析仅限于2020 - 2021年时,COVID-19的诊断编码与VTE诊断几率增加1.35倍(95%置信区间:1.24 - 1.45)相关,但与AIS无关。药物性血栓预防的使用从2018 - 2019年住院患者的1.5%增加到2020 - 2021年住院患者的3.0%(P <.001)。在评估2020 - 2021年期间的血栓预防时,COVID-19的诊断编码与药物性血栓预防使用率增加11倍(95%置信区间:10.86 - 11.49;P <.001)相关。

结论

本研究发现大流行期间住院儿童中VTE的发生率有所增加。COVID-19的诊断与VTE诊断几率适度增加相关,尽管药物性血栓预防的使用有所增加,但仍出现了这种情况。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验